Thermo Fisher Scientific Inc. (TMO): Price and Financial Metrics


Thermo Fisher Scientific Inc. (TMO): $465.15

0.24 (+0.05%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TMO POWR Grades


  • TMO scores best on the Growth dimension, with a Growth rank ahead of 95.97% of US stocks.
  • The strongest trend for TMO is in Stability, which has been heading down over the past 31 weeks.
  • TMO ranks lowest in Momentum; there it ranks in the 15th percentile.

TMO Stock Summary

  • With a market capitalization of $176,159,028,784, Thermo Fisher Scientific Inc has a greater market value than 98.88% of US stocks.
  • Thermo Fisher Scientific Inc's stock had its IPO on September 1, 1987, making it an older stock than 91.49% of US equities in our set.
  • In terms of volatility of its share price, TMO is more volatile than only 2.68% of stocks we're observing.
  • Stocks that are quantitatively similar to TMO, based on their financial statements, market capitalization, and price volatility, are TXN, COST, MDT, SAP, and TMUS.
  • Visit TMO's SEC page to see the company's official filings. To visit the company's web site, go to www.thermofisher.com.

TMO Price Target

For more insight on analysts targets of TMO, see our TMO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $558.08 Average Broker Recommendation 1.36 (Strong Buy)

TMO Stock Price Chart Interactive Chart >

Price chart for TMO

TMO Price/Volume Stats

Current price $465.15 52-week high $532.57
Prev. close $464.91 52-week low $330.57
Day low $461.15 Volume 1,935,100
Day high $465.90 Avg. volume 1,825,052
50-day MA $467.45 Dividend yield 0.22%
200-day MA $465.80 Market Cap 182.82B

Thermo Fisher Scientific Inc. (TMO) Company Bio


Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues. (Source:Wikipedia)

TMO Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$465.15$439.22 -5%

We started the process of determining a valid price forecast for Thermo Fisher Scientific Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Thermo Fisher Scientific Inc ranked in the 53th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Thermo Fisher Scientific Inc ended up being:

  • Interest coverage, a measure of earnings relative to interest payments, is 17.58; that's higher than 74.83% of US stocks in the Healthcare sector that have positive free cash flow.
  • TMO's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 38.15% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-7%
1%-6%
2%-5%
3%-4%
4%-3%
5%-2%

Want more companies with a valuation profile/forecast similar to that of Thermo Fisher Scientific Inc? See PCRX, ITGR, LCI, AMED, and LMAT.


TMO Latest News Stream


Event/Time News Detail
Loading, please wait...

TMO Latest Social Stream


Loading social stream, please wait...

View Full TMO Social Stream

Latest TMO News From Around the Web

Below are the latest news stories about Thermo Fisher Scientific Inc that investors may wish to consider to help them evaluate TMO as an investment opportunity.

In-Vitro Diagnostics Market 2021 is Poised To Value Over US$ 90,656.80 million by 2027 with Business Market Insights: Biomérieux SA, Bio-Rad Laboratories, INC., Qiagen, Danaher, Thermo Fisher Scientific, Inc.

The In-Vitro Diagnostics Market was valued at US$ 63,746.63 million in 2021 and it is projected to reach US$ 90,656.80 million by 2027; it is expected to grow at a CAGR of 4.5% from 2020 to 2027. In-vitro diagnostics are examinations

OpenPR | June 10, 2021

Preimplantation Genetic Diagnosis Market 2021-2028 Industry Analysis by Key Players - Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Perkinelmer, Inc., Coopersurgical, ABBott Laboratories

Global Preimplantation Genetic Diagnosis Market research report offers an inclusive and decision-making overview, including product definition, market characteristics, segmentation, constraints, challenges and drivers. The report describes detailed information about Preimplantation Genetic Diagnosis market share, emerging market trends, supply chain analysis,

OpenPR | June 10, 2021

Global Water Quality Monitoring Equipment Market Growth 2021: Covid-19 Impact Analysis Report By Industry Share- GE Water & Process Technologies, HORIBA, In-Situ, Thermo Fisher Scientific, YSI

COVID-19 Impact on Global Water Quality Monitoring Equipment Market Professional Survey Research Report 2021-2027 The global Water Quality Monitoring Equipment market report examines the market position and viewpoint of the market worldwide, from various angles, such as from the key players point, geological regions, types of product and application. This Water Quality Monitoring Equipment report []

Jumbo News | June 10, 2021

U.S. senator slams Apple, Amazon, Nike, for enabling forced labor in China

A U.S. senator on Thursday slammed American companies, including Amazon.com Inc, Apple Inc and Nike Inc, for turning a blind eye to allegations of forced labor in China, arguing they were making American consumers complicit in Beijing's repressive policies. Speaking at a Senate Foreign Relations Committee hearing on China's crackdown on Uyghurs and other Muslim minorities in its western Xinjiang region, Republican Senator Marco Rubio said many U.S. companies had not woken up to the fact that they were "profiting" from the Chinese government's abuses.

Yahoo | June 10, 2021

Stem Cell Manufacturing Market Size to Reach USD 28.85 Billion in 2028: Reports and Data

Major players in the stem cell manufacturing market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others. Major players in the stem cell manufacturing market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osi...

Intrado Digital Media | June 9, 2021

Read More 'TMO' Stories Here

TMO Price Returns

1-mo 1.38%
3-mo 4.25%
6-mo 1.72%
1-year 37.20%
3-year 117.19%
5-year 220.18%
YTD -0.02%
2020 43.72%
2019 45.55%
2018 18.21%
2017 35.03%
2016 -0.12%

TMO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TMO Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 10.3699 seconds.